Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3743 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Astellas blood sodium drug approved

The drug is for in hospitalized patients with the blood sodium illness hypervolemic hyponatremia. Vaprisol is the first drug specifically indicated for the treatment of both euvolemic and

Sanofi launches affordable malaria drug

The pill, known as ASAQ, is a combination of two drugs already known to be effective against malaria, artesunate and amodiaquine. As well as being affordable the pill

FDA accepts Pharmion myeloma drug for review

The application is based upon a clinical data package comprised of four studies, including a study that showed a 21-month survival advantage when Thalidomide was added to the

GSK vaccine suggests efficacy in hepatitis E

Hepatitis E, a waterborne strain of hepatitis that occurs almost exclusively in the developing world, is currently without cure or medical prophylaxis. In the trial three doses were

EU recommends extended indication for Prevenar

Prevenar is currently approved for active immunization of children from 2 months to 5 years of age against sepsis, meningitis, bacteraemic pneumonia and bacteraemia. Pneumococcal disease is a

ImmuneRegen will test influenza drug with Tamiflu

Tamiflu is an FDA-approved treatment and prophylactic against influenza and is being purchased and stockpiled by worldwide in anticipation of a feared pandemic influenza outbreak. ImmuneRegen said if